HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
This event, organized by France BioLead and placed under the patronage of French President Emmanuel Macron, aims to highlight a strategic sector at the heart of healthcare and innovation.
We have always been committed to developing innovative biotechnology solutions, and every day we contribute to advancing biomanufacturing in France and internationally.
Our commitment is to promote biomanufacturing in France and worldwide.
Find below the official JNBB 2025 press release:
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.
This October, HTL Biotechnology turned pink to support breast cancer prevention.
HTL Biotechnology is the winner of the Responsible Care West Atlantic Trophy in the ‘Energy – Climate’ category for its project to reduce carbon emissions from distillation systems.